APA (7th ed.) Citation

Schreiber, F., Piontek, G., Schneider-Kimoto, Y., Schwarz-Furlan, S., De Vito, R., Locatelli, F., . . . Rudelius, M. (2023). Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation. Cancers, 15(23), 5594. https://doi.org/10.3390/cancers15235594

Chicago Style (17th ed.) Citation

Schreiber, Franziska, et al. "Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation." Cancers 15, no. 23 (2023): 5594. https://doi.org/10.3390/cancers15235594.

MLA (9th ed.) Citation

Schreiber, Franziska, et al. "Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation." Cancers, vol. 15, no. 23, 2023, p. 5594, https://doi.org/10.3390/cancers15235594.